VVV
Veraxa Biotech AG
No trades
0.21 USD
8.99 M USD
0.00 USD
About Veraxa Biotech AG
Sector
Industry
CEO
Christoph Antz
Headquarters
Zurich
Founded
2025
Identifiers
2
ISIN CH1476899161
Veraxa Biotech Holding AG engages in operating an oncology-focused biotechnology company, which is the Veraxa Biotech AG (Company). The Company focuses on the development of novel antibody-based drug platforms for the treatment of cancer. The company was founded on June 25, 2025 and is headquartered in Zurich, Switzerland.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently asked questions
The current price of VRXA is 5.86 USD — it has decreased by −55.50% in the past 24 hours. Watch Veraxa Biotech AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Veraxa Biotech AG stocks are traded under the ticker VRXA.
VRXA stock has fallen by −32.43% compared to the previous week, the month change is a −8.95% fall, over the last year Veraxa Biotech AG has showed a −43.55% decrease.
VRXA reached its all-time high on Jun 11, 2026 with the price of 27.36 USD, and its all-time low was 7.82 USD and was reached on Jun 16, 2026. View more price dynamics on VRXA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VRXA stock is 88.44% volatile and has beta coefficient of −0.39. Track Veraxa Biotech AG stock price on the chart and check out the list of the most volatile stocks — is Veraxa Biotech AG there?
Yes, you can track Veraxa Biotech AG financials in yearly and quarterly reports right on TradingView.
VRXA net income for the last quarter is 180.50 K USD, while the quarter before that showed 1.71 M USD of net income which accounts for 0.00% change. Track more Veraxa Biotech AG financial stats to get the full picture.
No, VRXA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 18, 2026, the company has 3 employees. See our rating of the largest employees — is Veraxa Biotech AG on this list?
Like other stocks, VRXA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Veraxa Biotech AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Veraxa Biotech AG technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Veraxa Biotech AG stock shows the strong sell signal. See more of Veraxa Biotech AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.